Board to consider preferential issue of shares and warrants
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.5 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board meeting to consider a preferential issue of equity shares and warrants has been moved from 26 October 2026 to 29 October 2026. The proposal remains subject to approvals. The filing does not state the issue price, number of securities, investor names or warrant terms.
The issue could dilute existing shareholders. Price, investor identity and warrant terms are unknown, so the likely stock-price effect cannot be assessed.